| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0e67818ab2d3b97121031ecfbb559e1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2002-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2002-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2002-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2006-80 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01G28-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01G28-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 |
| filingDate |
2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c39089f2b7cae5a767a564e1d6a58f10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c3b5dfa897f5a7b1f258a807ce6b0bf |
| publicationDate |
2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112019009483-A2 |
| titleOfInvention |
pharmaceutical composition for the prevention or treatment of breast cancer, including tetra-arsenic hexoxide crystalline polymorph, and method for producing the same |
| abstract |
The present invention relates to a pharmaceutical composition for the prevention or treatment of breast cancer which includes tetraarsenic hexoxide, wherein a (as4o6-a) crystalline tetraarsenic hexoxide polymorph is present in 99% or greater, and to a method to produce it. The composition of the present invention exhibits excellent inhibition effects of cancer cell proliferation and metastasis, and thus may usefully be employed as an anticancer agent. |
| priorityDate |
2016-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |